These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 15693639)
1. The pathophysiology of airway dysfunction. Doherty DE Am J Med; 2004 Dec; 117 Suppl 12A():11S-23S. PubMed ID: 15693639 [TBL] [Abstract][Full Text] [Related]
2. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Tamimi A; Serdarevic D; Hanania NA Respir Med; 2012 Mar; 106(3):319-28. PubMed ID: 22196881 [TBL] [Abstract][Full Text] [Related]
3. Distinguishing adult-onset asthma from COPD: a review and a new approach. Abramson MJ; Perret JL; Dharmage SC; McDonald VM; McDonald CF Int J Chron Obstruct Pulmon Dis; 2014; 9():945-62. PubMed ID: 25246782 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment. Perng DW; Huang HY; Chen HM; Lee YC; Perng RP Chest; 2004 Aug; 126(2):375-81. PubMed ID: 15302720 [TBL] [Abstract][Full Text] [Related]
5. Differences in airway remodeling between asthma and chronic obstructive pulmonary disease. Aoshiba K; Nagai A Clin Rev Allergy Immunol; 2004 Aug; 27(1):35-43. PubMed ID: 15347849 [TBL] [Abstract][Full Text] [Related]
6. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome. Nakawah MO; Hawkins C; Barbandi F J Am Board Fam Med; 2013; 26(4):470-7. PubMed ID: 23833163 [TBL] [Abstract][Full Text] [Related]
7. The Role of Lymphocytes in the Pathogenesis of Asthma and COPD. Baraldo S; Lokar Oliani K; Turato G; Zuin R; Saetta M Curr Med Chem; 2007; 14(21):2250-6. PubMed ID: 17896974 [TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Gosens R; Zaagsma J; Meurs H; Halayko AJ Respir Res; 2006 May; 7(1):73. PubMed ID: 16684353 [TBL] [Abstract][Full Text] [Related]
9. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease? Reddy CB; Kanner RE Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532 [TBL] [Abstract][Full Text] [Related]
10. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. Hizawa N Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ; Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710 [TBL] [Abstract][Full Text] [Related]
12. Use of inhaled anticholinergic agents in obstructive airway disease. Restrepo RD Respir Care; 2007 Jul; 52(7):833-51. PubMed ID: 17594728 [TBL] [Abstract][Full Text] [Related]